Unclaimed brand
A leading clinical-stage biotechnology company focused on the design and development of first-in-class anti-infectives for difficult-to-treat diseases
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#008D9D
Deep Cerulean
0, 141, 157
186, 100, 31
100, 10, 0, 38
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#444444
Tundora
68, 68, 68
0, 0, 27
0, 0, 0, 73
NovaBiotics is a clinical-stage biotechnology company developing first-in-class solutions for unmet needs in health and personal care. Its work focuses on anti-infective approaches for difficult-to-treat diseases, including infectious and respiratory conditions, and research addressing antimicrobial resistance. The company’s pharmaceutical pipeline includes cysteamine-based candidates NM001 and NM002, with research exploring cysteamine’s antiviral, anti-inflammatory and potential role in mycobacterial disease, including tuberculosis. NovaBiotics is investigating this potential in collaboration with the Liverpool School of Tropical Medicine.
Alongside its pharmaceutical research, NovaBiotics develops personal care products through NovaBiotics Consumer Health. Its Tinexyl range includes Tinexyl PRO, a conditioning product designed to support toenail health and available through UK podiatrists and foot health practitioners. The company has also announced distribution arrangements to support commercialisation of its nail-care products.
Based in Aberdeen, NovaBiotics operates in the biotechnology and consumer health sectors, combining research and development with product development and commercial partnerships. Its activities span therapeutic innovation and practical personal care solutions.
Company type
Privately Held
Year founded
2004
Company size
11-50 employees
